CareDx
In Brief This Week: Quanterix, Cue Health, Hologic, CareDx, and More
News items for the in vitro diagnostics industry for the week of Oct. 11, 2021.
Broader Markets Weigh Down Dx Stocks, 360Dx Index Falls 4 Percent in September
Of the 29 companies in the index, three saw increases in their stock prices, while 26 saw declines.
CareDx Patents Deemed Invalid in Court Battle Against Natera, Eurofins Viracor
In a separate case in which CareDx and Natera are suing each other for false advertising, a court has set a trial date in late October.
360Dx Index Maintains Steady Ascent, Increasing 3 Percent in August
Of the 29 companies in the index, 18 saw increases in their stock prices, while 11 saw declines.
CareDx Q2 Revenues up 77 Percent
The company reported $74.2 million in total revenues for the quarter and said testing service revenues rose 79 percent year over year.
May 5, 2021
CareDx Q1 Revenues up 76 Percent
Feb 25, 2021
Feb 24, 2021
CareDx Q4 Revenues Up 64 Percent
Jan 21, 2021
CareDx Prices $175M Common Stock Offering
Oct 29, 2020